IL92513A0 - Lysoganglioside derivatives - Google Patents

Lysoganglioside derivatives

Info

Publication number
IL92513A0
IL92513A0 IL92513A IL9251389A IL92513A0 IL 92513 A0 IL92513 A0 IL 92513A0 IL 92513 A IL92513 A IL 92513A IL 9251389 A IL9251389 A IL 9251389A IL 92513 A0 IL92513 A0 IL 92513A0
Authority
IL
Israel
Prior art keywords
acyl
lysogangliosides
group
lysoganglioside derivatives
lysoganglioside
Prior art date
Application number
IL92513A
Other languages
English (en)
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of IL92513A0 publication Critical patent/IL92513A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
IL92513A 1988-12-02 1989-12-01 Lysoganglioside derivatives IL92513A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848618A IT1235161B (it) 1988-12-02 1988-12-02 Derivati di lisogangliosidi

Publications (1)

Publication Number Publication Date
IL92513A0 true IL92513A0 (en) 1990-08-31

Family

ID=11267667

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92513A IL92513A0 (en) 1988-12-02 1989-12-01 Lysoganglioside derivatives

Country Status (15)

Country Link
EP (1) EP0373039B1 (de)
JP (1) JPH02200697A (de)
KR (1) KR910009721A (de)
AT (1) ATE103926T1 (de)
AU (1) AU630384B2 (de)
CA (1) CA2004189A1 (de)
DE (1) DE68914418T2 (de)
DK (1) DK589889A (de)
ES (1) ES2063156T3 (de)
FI (1) FI95577C (de)
HU (1) HU205129B (de)
IL (1) IL92513A0 (de)
IT (1) IT1235161B (de)
NO (1) NO173141C (de)
NZ (1) NZ231624A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1235011B (it) * 1988-07-26 1992-06-16 Fidia Farmaceutici Sintesi di derivati di glicosfingolipidi ed in particolare di gangliosidi utilizzabili per la preparazione di immunoadsorbenti ed adsorbenti per affinita' impiegabili per la purificazione di anticorpi e di tossine specifiche, e per uso diagnostico
IT1232175B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Analoghi semisintetici di gangliosidi
IT1232176B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
IT1239060B (it) * 1990-05-04 1993-09-20 Fidia Spa Processo per la modulazione selettiva dell'espressione e della funzione di un determinante sulla superficie cellulare attraverso appropriati agenti chimici
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi
IT1254280B (it) * 1992-03-13 1995-09-14 Fidia Spa Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson
US9023812B2 (en) 2009-09-04 2015-05-05 The Governors Of The University Of Alberta Neuroprotective ganglioside compositions for use in treating huntington's disease
ES2444269T3 (es) * 2010-07-23 2014-02-24 Loctite (R & D) Limited Método para la producción de anhídrido de ácido 2-cianoacético y otros productos de reacción correspondientes.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali
NZ222192A (en) * 1986-10-20 1991-03-26 Kanto Ishi Pharma Co Ltd Glycolipid containing n-glycolylneuraminic acid, and preparation thereof
IT1235011B (it) * 1988-07-26 1992-06-16 Fidia Farmaceutici Sintesi di derivati di glicosfingolipidi ed in particolare di gangliosidi utilizzabili per la preparazione di immunoadsorbenti ed adsorbenti per affinita' impiegabili per la purificazione di anticorpi e di tossine specifiche, e per uso diagnostico
GB8827967D0 (en) * 1988-11-30 1989-01-05 Ward I M Die-free drawing
NZ236059A (en) * 1989-11-17 1993-03-26 Fidia Spa Extraction of gangliosides

Also Published As

Publication number Publication date
CA2004189A1 (en) 1990-06-02
HU896337D0 (en) 1990-02-28
DE68914418D1 (de) 1994-05-11
NO894820D0 (no) 1989-12-01
IT1235161B (it) 1992-06-22
EP0373039A2 (de) 1990-06-13
IT8848618A0 (it) 1988-12-02
HUT53116A (en) 1990-09-28
DK589889D0 (da) 1989-11-23
NO173141C (no) 1993-11-03
HU205129B (en) 1992-03-30
FI95577C (fi) 1996-02-26
NO173141B (no) 1993-07-26
EP0373039B1 (de) 1994-04-06
DK589889A (da) 1990-06-03
ES2063156T3 (es) 1995-01-01
KR910009721A (ko) 1991-06-28
AU4571889A (en) 1990-06-07
FI895765A0 (fi) 1989-12-01
DE68914418T2 (de) 1994-10-06
AU630384B2 (en) 1992-10-29
NZ231624A (en) 1992-03-26
EP0373039A3 (de) 1991-06-05
NO894820L (no) 1990-06-05
ATE103926T1 (de) 1994-04-15
JPH02200697A (ja) 1990-08-08
FI95577B (fi) 1995-11-15

Similar Documents

Publication Publication Date Title
AU632771B2 (en) New lysosphingolipid derivatives
IL92513A0 (en) Lysoganglioside derivatives
PL286248A1 (en) Method of obtaining novel derivatives of gangliosides
PL286249A1 (en) Method of obtaining semisynthetic analogues of gangliosides